China Atrial Fibrillation Screening in Acute Ischemic Stroke Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-10-31

Study Completion Date

2015-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Three purpose of this study:

1. Increase diagnosis rate and formulate the flow of diagnosis and treatment of AF in ischemic stroke patients;
2. Evaluation on specificity and sensitivity of STAF score;
3. Analyze the pathogenesis of ischemic stroke and risk factors and establish clinical database and sample database of ischemic stroke.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

REperfusion Therapy for Acute Ischemic STrOke Due to Large aRtEry Occlusion

NCT05311605

Stroke Vascular Occlusion Endovascular Treatment +2 more

RECRUITING

Endovascular treatmenT for Acute Ischemic Stroke in China

NCT04752735

Stroke Endovascular Treatment

COMPLETED

Exploration and Establishment of an Early Warning System for Futile Reperfusion - A I S

NCT07045987

Acute Ischemic Stroke (AIS) Endovascular Thrombectomy Neurovascular Unit- Brain Lymphatic System

ENROLLING_BY_INVITATION

Improve Acute Reperfusion Treatment Quality for Stroke in China, IMPROVE: Stroke Care in China

NCT03578107

Ischemic Stroke

COMPLETED NA

Chinese Acute Ischemic Stroke Treatment Outcome Registry

NCT02470624

Ischemic Stroke

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Inclusion criteria:

1. Hospitalized patients with ischemic stroke that are diagnosed definitely;
2. Age ≥ 18 years;
3. Within 7 days after the onset of diseases;
4. Signed the consent informed form.

Exclusion criteria:

1. Patients with noncerebrovascular diseases that are diagnosed definitely;
2. Silent cerebral infarction (CI) without symptoms and signs;
3. Those refuse to sign the consent informed form of the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Hospitalized patients with ischemic stroke that are diagnosed definitely;
2. Age ≥ 18 years;
3. Within 7 days after the onset of diseases;
4. Signed the consent informed form.

Exclusion Criteria

1. Patients with noncerebrovascular diseases that are diagnosed definitely;
2. Silent cerebral infarction (CI) without symptoms and signs;
3. Those refuse to sign the consent informed form of the study.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No